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Abstract
The aim of this work was to track and verify the delivery of respiratory-
gated irradiations, performed with three versions of TrueBeam linac, using 
a novel phantom arrangement that combined the OCTAVIUS® SRS 1000 
array with a moving platform. The platform was programmed to generate 
sinusoidal motion of the array. This motion was tracked using the real-time 
position management (RPM) system and four amplitude gating options were 
employed to interrupt MV beam delivery when the platform was not located 
within set limits. Time-resolved spatial information extracted from analysis 
of x-ray fluences measured by the array was compared to the programmed 
motion of the platform and to the trace recorded by the RPM system during 
the delivery of the x-ray field. Temporal data recorded by the phantom and the 
RPM system were validated against trajectory log files, recorded by the linac 
during the irradiation, as well as oscilloscope waveforms recorded from the 
linac target signal. Gamma analysis was employed to compare time-integrated 
2D x-ray dose fluences with theoretical fluences derived from the probability 
density function for each of the gating settings applied, where gamma criteria 
of 2%/2 mm, 1%/1 mm and 0.5%/0.5 mm were used to evaluate the limitations 
of the RPM system. Excellent agreement was observed in the analysis of spatial 
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information extracted from the SRS 1000 array measurements. Comparisons 
of the average platform position with the expected position indicated absolute 
deviations of  <0.5 mm for all four gating settings. Differences were observed 
when comparing time-resolved beam-on data stored in the RPM files and 
trajectory logs to the true target signal waveforms. Trajectory log files 
underestimated the cycle time between consecutive beam-on windows by 
10.0  ±  0.8 ms. All measured fluences achieved 100% pass-rates using gamma 
criteria of 2%/2 mm and 50% of the fluences achieved pass-rates  >90% 
when criteria of 0.5%/0.5 mm were used. Results using this novel phantom 
arrangement indicate that the RPM system is capable of accurately gating 
x-ray exposure during the delivery of a fixed-field treatment beam.
Keywords: time-resolved dosimetry, respiratory gating,  
treatment verification
S  Online supplementary data available from stacks.iop.org/PMB/61/5529/
mmedia
(Some figures may appear in colour only in the online journal)
1. Introduction
In recent years a number of new technologies have been introduced into the radiotherapy 
environment to improve the accuracy of external beam treatments. A large proportion of these 
tools are aimed at improving the geometric accuracy of individual patient’s treatments, with 
the goals of ensuring accurate dose delivery to the target volume and reducing harmful side-
effects from normal tissue toxicity. The introduction of respiratory gating technology is an 
example of this, where motion of a target volume is tracked, either directly or through the 
use of a surrogate, and irradiation from the linac is only enabled when set constraints are 
met (Korreman 2008). The real-time position management™ (RPM) system (Varian Medical 
Systems, Palo Alto) is a video-based gating system designed to correlate x-ray exposures with 
the monitored position of an infrared marker block and to interrupt treatment exposures if 
the respiratory signal is not within set constraints. The RPM system can be incorporated into 
both imaging and treatment modalities. Studies have therefore been conducted to verify the 
geometric accuracy of axial CT images correlated to the RPM respiratory signal (Yamamoto 
et al 2008, Nakamura et al 2009,O’Connell et al 2015), as well as evaluate its effectiveness at 
reducing respiration-induced treatment uncertainty (Ford et al 2002, Berbeco et al 2005, Tai 
et al 2010).
The incorporation of gating technology into treatment exposures adds another degree of 
complexity to the dosimetric verification of treatment delivery. Additional tests are recom-
mended to verify accurate communication between the gating system and the linac control 
unit and ensure accurate delivery of the planned treatment dose (Keall et al 2006). A number 
of approaches have been suggested for dosimetric quality assurance (QA) of respiratory gated 
treatments. Radiographic/radiochromic film and ionisation chamber measurements are tools 
commonly employed to validate new radiotherapy technology and a number of early studies 
reported positive results using these tools when combined with custom built moving plat-
forms (Kubo et al 2000, Hugo et al 2002). However, for intensity modulated radiation therapy 
(IMRT), it was highlighted that the addition of gating to a patient’s treatment has the potential 
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to introduce additional dosimetric errors depending on the method used to modulate the x-ray 
fluence (Duan et al 2003).
Phantom arrangements that incorporate 2D dosimetry arrays have also been proposed for 
the verification of gated treatments. A prototype device designed by Nelms et al (2007) com-
bined the MapCHECK 2D diode array (Sun Nuclear Corporation, Melbourne, FL) with a 
high-precision programmable platform capable of independent motion in two dimensions. 
The authors found that the device was effective at quantifying the degradation in dose uni-
formity that results from a moving target and that it could easily be integrated with the RPM 
gating system for QA purposes.
More recently, Woods and Rong (2015) published a report on the development of a com-
prehensive QA program for the testing of the RPM system. This QA scheme employed the 
CIRS dynamic thoracic phantom (CIRS Inc., Norfolk, VA), together with radiochromic film 
and optically stimulated luminescence detectors, for 2D fluence and point dose checks. The 
scheme was tested across 8 TrueBeam linacs (Varian Medical Systems), where the authors 
also utilised on-board kV and MV-portal imagers to verify the temporal accuracy of the RPM 
beam-enable gates. Film measurements were found to be within 3% of expected for a 7-field 
IMRT plan delivered under gating conditions with the phantom moving sinusoidally. Using 
additional data from other sources (McCabe and Wiersma 2014), the authors estimated the 
temporal accuracy of the beam-enable gates to be 139  ±  10 ms for MV imaging beams and 
92  ±  11 ms for kV beams. These uncertainties are of a similar magnitude to those measured 
by other groups (e.g. Chang et al (2011)), who reported delays of 90  ±  10 ms using gafchro-
mic film for MV beams gated with the RPM system.
An alternative approach to measuring dose distributions is to exploit the log files that are 
generated by Varian linacs during the delivery of an external beam treatment. The merits of 
log-file-based dose reconstruction for patient-specific QA of IMRT techniques have previously 
been reported by a number of groups (Litzenberg et al 2002, Agnew et al 2012, Sun et al 
2013). This technique has also been assessed for the purposes of gated-volumetric modulated 
arc therapy (VMAT) verification (Qian et al 2011). Qian et al verified the results of the log-file-
based reconstructed dose against planar fluences, acquired using a 2D ion chamber array, and 
observed 93.5–100% gamma agreement between the two techniques using 3%/3 mm criteria.
While many of the reported studies (e.g. Kubo et al (2000), Nelms et al (2007), Woods 
and Rong (2015)) have proposed time-integrated techniques to dosimetrically verify gated 
beam delivery, the time-dependent triggering inherent in these treatments emphasises the need 
for time-resolved dosimetry to fully validate their delivery. Respiratory gating is typically 
employed in combination with highly conformal techniques such as VMAT and stereotac-
tic ablative radiotherapy (SABR). These techniques are complex to both plan and to verify 
the delivery accuracy. Nordström et  al (2013) highlighted the potential for delivery errors 
at certain gantry angles to be blurred during integrated verification of VMAT deliveries and 
recommended the use of time-resolved ‘4D’ dosimetry to evaluate the delivery at the control 
point level to enable observation of systematic and plan-specific errors. The complexity of 
these treatment techniques is further exacerbated when motion and gating are included and it 
is therefore important for gating techniques to be verified independently (to isolate any errors) 
before evaluating them in combination with VMAT or SABR.
In this report we propose a novel phantom arrangement that enables the acquisition of 
time-resolved 2D dose fluences from within the patient’s frame of reference by combining a 
high resolution 2D ionisation chamber array (capable of 100 ms temporal resolution) with a 
programmable moving platform. This phantom arrangement was tested using the RPM sys-
tem installed on four TrueBeam linacs, where it’s time-resolved data was validated against 
several data sources and its integrated x-ray fluences were compared to expected fluences. 
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It is expected that the periodic sampling of gated x-ray exposures with this arrangement will 
enable a more robust validation of gated treatments by evaluating the gated x-ray output in 
both spatial and temporal domains.
2. Materials and methods
2.1. Dose delivery system
Four TrueBeam linacs, operating with 3 different version iterations (two v1.5, a v1.6 and a v2.0), 
were studied in this investigation. A single 6 MV x-ray field was used to deliver 200 monitor 
units (MU) to the phantom arrangement from a static gantry angle. The x-rays were confined to 
a fixed field size of 4  ×  4 cm2 and delivered at a nominal dose-rate of 600 MU min−1.
2.2. Gated exposure delivery
Each linac was equipped with the RPM system which is composed of a ceiling mounted stereo 
camera, enclosing two detectors each surrounded by an array of infrared light-emitting diodes 
(LEDs). The LEDs illuminate a marker block, containing four reflective markers, placed on 
the patient’s surface. The markers reflect the infrared light onto the stereo camera allowing 
its position to be tracked at a frequency of 30 Hz, along the three Cartesian axes. The track-
ing signal is interpreted by a workstation that is capable of invoking different gating options 
including amplitude and phase-based gating. When the position of the marker block is outside 
the constraints set on the workstation a beam-disable (beam-hold) gate is exerted on the linac 
radiation output.
The amplitude gating constraints used throughout this investigation are illustrated as a 
schematic in figure 1(a) for a sinusoidal oscillation of 2.5 cm amplitude. Four different ampl-
itude constraints were used to gate the radiation output from the linac so that it was only ena-
bled when the phantom was within  ±30% and  ±20% of its central position (gating settings A 
and B respectively), and at each 20% extreme of its motion (i.e. end inspiration and end expi-
ration, gating settings C and D respectively). Exposures without gating were also performed 
for each breathing period and an additional exposure was carried out on each TrueBeam when 
the phantom was static with the detector aligned along the linac isocentre.
2.3. Acquisition arrangement
A schematic of the experimental arrangement used to acquire time resolved 2D dose fluences 
during the irradiations is displayed in figure 1(b) adjacent to a photograph of the arrangement 
in figure 1(c). The moving platform used in this investigation has been described previously 
(Chinneck et  al 2010, Cole et  al 2012) and is based on a design originally described by 
Dietrich et al (2005). The motion of the platform is controlled through the use of machined 
disks that recreate different breathing patterns. In this investigation a sinusoidal oscillation 
with a peak-to-trough amplitude of 2.5 cm was used for all irradiations. The oscillation period 
of the platform can be adjusted using an analogue control. Studies elsewhere have reported 
that the typical breathing cycle for a healthy individual has a period of approximately 4 s 
(range 2.7–6.6 s, Seppenwoolde et al 2002). Therefore, breathing periods of 3, 4 and 6 s were 
chosen to represent a typical range of periods.
The Varian RPM four point reflector block was positioned on a shelf attached to the moving 
platform so that it could be observed within the field of view of the RPM detection system. 
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The shelf was mounted such that it moved across a 45° wedge, relative to the platform surface. 
This resulted in vertical translations of the shelf that were synchronised with the horizontal 
motion of the platform and were of the same amplitude.
2.3.1. OCTAVIUS SRS array. The OCTAVIUS® SRS 1000 array (PTW, Freiburg, Germany) 
was positioned on the moving platform so that its detection plane was aligned with the iso-
centre of the linac, with 5 cm of WTe solid water material (Barts and The London NHS Trust, 
London, UK) placed above and below the detector to act as build-up and backscatter material 
respectively. The 2D array consists of 977 liquid-filled ionization chambers distributed across 
a square active detection region of area 11  ×  11 cm2, with variable detector spacing across this 
area. The maximum physical resolution of the array is 2.5 mm which is achieved over an area 
of 5  ×  5 cm2 within its central region and along the primary orthogonal axis. The remaining 
area within the detection region is sampled by chambers that are distributed with a check-
erboard pattern. Verisoft v6.2 acquisition and analysis software (PTW) was used to acquire 
time-resolved 2D fluences of the dose with a temporal resolution of 100 ms.
2.3.2. Linac target signal tracking. To provide additional data on the dosimetric output of the 
linac during the irradiations, an oscilloscope was used to probe the TrueBeam digital output 
of the linac target current.
2.3.3. RPM data. Following each gated irradiation, the offline review program (Varian Medi-
cal Systems) was used to examine the motion traces recorded by the RPM system. The data 
presented in offline review includes a temporal trace of the motion interpreted from the RPM 
camera system, the set amplitude constraints and gates to indicate the time periods when the 
trace is within the set gating parameters. The recorded data for each of the gated exposures 
were exported (via Aria version 11) as tab-delimited txt files with an interpolated sampling 
rate of 67 Hz, and imported into MATLAB V.7.10.0 (MathWorks, Natick, MA) to allow com-
parison with the other sources of time-resolved data.
2.3.4. Trajectory logs. Trajectory log files recorded during the irradiations were analysed 
using in-house software written in MATLAB (Agnew et  al 2014). During each clinical 
Figure 1. Experimental arrangement. (a) Schematic indicating the amplitude gating 
constraints applied to a 2.5 cm sinusoidal oscillation. (b) Schematic illustrating 
the position of the OCTAVIUS SRS array on the programmable moving platform. 
(c) Photograph of the phantom arrangement positioned below the treatment head of a 
TrueBeam linac.
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irradiation the console of the TrueBeam linac will record data every 20 ms to a single trajec-
tory log file. A detailed description on the information recorded within these log files can be 
obtained from Varian (Varian Medical Systems 2011, 2013).
2.4. Temporal and spatial analysis of time-resolved data
The Verisoft output files were imported into MATLAB for analysis. An example of a 2D flu-
ence measured during a 100 ms time interval is displayed in figure 2(a). For each 2D acquisi-
tion a 1D profile was taken through the dose fluence along the central axis of the array, parallel 
to the direction of the platform’s motion (figure 2(b)). The superior and inferior coordinates 
where the dose was 50% of the maximum (dash-dot grey lines in figure 2) were determined to 
an interpolated resolution of 0.25 mm. The centre of the spatial profile was determined from 
the average of these coordinates (dashed line), and used to track the motion of the dose profile 
across the SRS array.
Figure 2(c) displays an example of how these three points varied over time for a continuous 
exposure using a 6 s breathing period. Analysis was performed on the SRS array-generated 
time-resolved traces for each gating condition and breathing period for the four TrueBeam lin-
acs. The mean and standard deviation of the spatial coordinates extracted over the entire expo-
sure were calculated and compared to that expected for a finitely sampled sinusoidal trace.
As each of the four sources of time-resolved data was recorded on separate workstations, 
the timestamps of their respective data samples were not synchronised and it was necessary 
to determine appropriate delays between the individual datasets. Although the target signal 
was considered the ground truth throughout this investigation, the RPM data was used to syn-
chronise each of the data sources as they included both spatial data and gates to indicate when 
set amplitude constraints were met. For SRS array measurements, the time-resolved spatial 
profiles were compared to the marker block position traces recorded by the RPM system. 
The data recorded by the two data sources during the first beam-on period (i.e. first exposure 
Figure 2. Analysis of time-resolved 2D dose fluences. (a) Example 2D dose fluence. 
Solid vertical line indicates plane used to derive 1D profile of the variation of dose 
across the area of the detector. (b) Profile taken along the sample plane. (c) Time-
resolved plots of variation in location of the three reference points during an exposure 
when the platform oscillated with a period of 6 s. Colour available online only.
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segment) were compared and a temporal delay was introduced into the SRS array data to 
achieve the best agreement.
To derive a suitable correction factor for the target signal and trajectory log datasets, the 
RPM beam-disable gate corresponding to the deactivation of the first segment was selected as 
the reference to compare to the RPM data. A delay was introduced to the time axis of both the 
trajectory log files and the target signal data so that the first segment’s beam-off flag occurred 
at the same time for the three data sources. While the SRS array and target signal data were 
recorded on independent workstations, the trajectory log files were generated by a Varian 
workstation that communicates with the RPM system. The delay term derived from compar-
ing these two data sources therefore effectively indicated a delay in the automatic commence-
ment of digital recording by the RPM and linac control systems.
Further analysis was performed to ensure that the four data sources remained synchro-
nised throughout each gated exposure. Beam-on flags interpreted from the target signal were 
used as the ground truth reference to compare to the other data sources. The time difference 
(Δt) between the reference signal beam-on flag (tref) and the beam-on/beam-enable times 
from the three additional data sources (tx) were then determined for each segment (i) (i.e. 
( ) ( ) ( )∆ = −t i t i t ix ref ). Negative values of Δt indicated that the gates/flags in the analysed 
signal occurred before the corresponding flags in the reference signal, while positive values 
indicated that the analysed signal was delayed with respect to the reference signal.
2.5. Gamma analysis
Gamma analysis was also employed to verify accurate delivery of the gated exposures. Using 
the technique described by Foster et al (2015), theoretically expected 2D dose fluences were 
generated by convolving a dose fluence, measured during an exposure when the SRS array 
was stationary, with the probability density function (PDF) of a 2.5 cm sinusoidal oscillation, 
confined to the same amplitude limits as the set constraints used in this investigation.
MATLAB was used to calculate the convolution of the static 2D fluence with the PDF of 
the expected gated motion and generate a theoretical 2D fluence for the gated acquisition. 
Verisoft was used to perform gamma analysis between the measured and theoretical dose 
distributions for each of the motion periods and gating settings, where a range of gamma cri-
teria (2%/2 mm, 1%/1 mm and 0.5%/0.5 mm) were used to assess the limitations of the gating 
modality.
3. Results
Figure 3 displays results from the four data sources for a gated exposure performed on a 
TrueBeam version 2.0. In this example the moving platform oscillated with a period of 4 s and 
RPM beam-enable amplitude gating constraints of 0.75 cm and 1.25 cm (i.e. end inspiration, 
gating setting C) were applied to the exposure. The time-resolved trace extracted from the 
SRS array data (black data points figures 3(a)–(c)) corresponds to the motion of the centre 
of the measured dose profile. For this acquisition the SRS array trace is observed to agree 
well with the measured RPM trace of the phantom motion (dashed grey line). The amplitude 
constraints are also indicated on this figure  by the dashed horizontal lines and the RPM-
determined beam-enable/disable gates corresponding to the platform position satisfying these 
constraints are overlaid as vertical dotted and dash-dotted lines respectively.
The solid grey bars in figures 3(d)–(f) indicate trains of individual pulses generated at a 
frequency of 360 Hz at the linac target during each irradiation segment. To summarise this 
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pulse train data, the timing of the initiation of the first pulse and the termination of last pulse 
for each segment was extracted to indicate beam-on/beam-off flags respectively. The results 
derived from this analysis are overlaid in the three plots (d)–(f) as a solid line.
The trajectory log data (figures 3(g)–(i)) indicate the beam-on status recorded in the log file 
in binary format. As no actual time information is logged in the trajectory log files, a 20 ms 
sampling interval (as defined in the trajectory log file specification (Varian Medical Systems 
2011, 2013)) has been assumed. The delay introduced to the trajectory log data to match the 
termination of the first exposure segment to the corresponding RPM beam-disable gate was 
observed to be very consistent for all the gated exposures investigated. TrueBeam version 2.0 
was observed to produce the most consistent log-file to RPM delay, with a mean of 4.623 s 
and a standard deviation of 0.019 s for the 12 gated exposures performed using this linac. 
The average delay for TrueBeam versions 1.5 and 1.6 were found to be very similar to this 
(4.614  ±  0.136 s and 4.578  ±  0.144 s respectively), albeit with a larger variation in the delay 
required for individual gated acquisitions. Additional time-resolved plots acquired using this 
arrangement on a TrueBeam v1.5 and the TrueBeam v2.0 are provided in appendix A of the 
supplementary material (stacks.iop.org/PMB/61/5529/mmedia).
3.1. OCTAVIUS SRS array spatial data
An average of 239  ±  28 beam-on samples were recorded by the SRS array for each gated 
exposure. These were analysed to determine the average position of the centre of the dose pro-
file for the gating setting used. The mean positions were compared to the expected values of 
0.0 mm for ungated exposures and gating settings A and B and  ±10.77 mm for the end inspi-
ration/expiration constraints (settings C or D). Table 1 reports the results of this analysis for 
Figure 3. Time-resolved data acquired by RPM system during a gated exposure 
compared to each of the other data sources. (a)–(c) Saved RPM trace (dark grey) 
compared to trace derived from SRS array measurements (black). (d)–(f) Measured 
target signal waveform. (g)–(i) Trajectory log file beam-on/off flags. (a), (d) and (g) 
correspond to the first radiation segment, (c), (f) and (i) correspond to the last segment 
and (b), (e) and (h) display data acquired in the intervening period. RPM beam enable/
disable gates are indicated in each plot by vertical dotted and dash-dot lines, respectively.
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the 12 ungated exposures and 48 gated exposures carried out in this investigation. The maxi-
mum absolute difference between the average measured and expected spatial position was 
0.42 mm for a 3 s oscillation irradiated using gating setting D (end expiration) by a TrueBeam 
v1.5. However, no apparent trends were observed in the calculated absolute differences with 
TrueBeam version, gating setting or breathing period applied during the exposure.
3.2. Phase consistency between data sources
It is apparent in figures 3(h) and (i) that the RPM beam-enable gates and trajectory log beam-
on flags do not remain synchronised throughout the entire exposure. In this example an 
accrued time delay of 130 ms was observed between the trajectory log beam-on flag and the 
RPM beam-enable gate for the last exposure segment. Analysis was therefore performed to 
determine the time differences between each of the data sources, as described in section 2.4. 
In this analysis, beam-on flags interpreted from the target signal for each segment were used 
as the ground truth reference with which to compare corresponding beam-on/-enable flags/
gates recorded by the SRS array, trajectory logs and RPM files. The results of this analysis are 
displayed as colour plots in figure 4 for gated exposures performed on the three versions of 
TrueBeam studied in this investigation. The colour scale used in the plots (available online) 
indicates the magnitude and direction of accumulated time differences between the three data 
sources and the reference target signal. Blue indicates that the beam-on time from the analysed 
data signal occurred before the corresponding beam-on time in the reference target signal, 
while red indicates that the analysed signal was delayed with respect to the reference.
The plots in figure 4 also illustrate how the total number of segments required to deliver 
200 MU varied as a function of both the gating constraints and the phantom oscillation period. 
The duration of the time window defining when particular gating constraints were satisfied 
decreased as the phantom breathing period increased. As a result, a larger number of segments 
were required when the fastest oscillation period of 3 s was used. The sinusoidal motion of 
the phantom also meant that the total number of segments for each irradiation was depend-
ent on the gating constraints used. Gating on the end inspiration or end expiration (settings C 
and D) required fewer segments to perform the exposure as these both corresponded to a duty 
cycle of 29.5% of an oscillation period, compared to 20.5% and 13.1% for settings A and B 
respectively.
Reviewing trends in the individual plots, good agreement was observed between the SRS 
array data and target signal data (figures 4(a)–(c)), as indicated by the predominantly green 
colour plots. The maximum discrepancy between these two data sources was 108 ms which is 
of a similar magnitude to the SRS array sampling temporal resolution (100 ms). A systematic 
trend was observed in the comparison between the trajectory log data and the target signal data 
(figures 4(d)–(f)). The increasing blue trend indicates that the trajectory log beam-on flags 
occurred prior to the corresponding target signal beam-on times, with the magnitude of the 
time difference increasing with each successive segment. This trend appeared to be consistent 
for all three versions of TrueBeam linac. An intermittent difference was also observed for a 
number of exposures when the RPM beam-enable gates were compared to the target signal 
beam-on flags (figures 4(g)–(i)). For versions 1.5 and 1.6 of TrueBeam there were a number 
of exposures where the RPM beam-enable gates occurred at an earlier time compared to the 
reference beam-on flags. The time difference between the two data sources was also found 
to increase between successive segments for these exposures. Additional time-resolved data 
acquired from all data sources is included in appendix A for a selection of the v1.5 (I) and v2.0 
exposures for comparison.
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To provide a quantifiable evaluation of the discrepancies observed between these data 
sources, the differences between the times recorded for the start of the last segment (N) of 
each gated exposure are reported in table 2. For this analysis the target signal beam-on flag 
time continued to be used as ground truth reference with which the log file’s beam-on flag 
and RPM beam-enable gate were compared. A large amount of variation is observed in the 
RPM delays for the two v1.5 TrueBeams and the v1.6 TrueBeam. The largest time difference 
observed for these three linacs was  −402 ms indicating that the last RPM beam-enable gate 
for this exposure occurred 402 ms before the beam-on flag interpreted from the target signal 
reference. Due to this intermittent discrepancy the average time difference for the 36 gated 
v1.5 and v1.6 exposures was  −192  ±  127 ms. Results for the 12 gated exposures performed 
on the TrueBeam v2.0 linac were more consistent, resulting in a smaller average and variation 
in the time differences calculated for this group of exposures (−35  ±  9 ms).
Figure 4. Time difference (Δt) between target signal segment beam-on time and 
beam-on/beam-enable time recorded by SRS array (a)–(c), trajectory logs (d)–(f) and 
the RPM system (g)–(i) for the three versions of TrueBeam linac. Y-axes of each plot 
indicate breathing period and gating setting described in figure 1(a). Colour available 
online only.
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Table 2 also illustrates the effects of the systematic trend observed between the linac target 
signal and the trajectory log data shown in figures 4(d)–(f). While the mean difference between 
the two data sources was very similar for the 4 linacs (approximately  −280  ±  130 ms), there 
was quite a large variation between the individual exposures for each linac. As previously 
indicated in figure 4, it is also evident from the table that the difference between the two data 
sources increased with the number of segments in an exposure, rather than the total irradiation 
time, with a maximum absolute difference of 600 ms recorded for an exposure consisting of 
N  =  59 segments.
3.3. Comparison between target signal and trajectory log data
The cause of the systematic difference between the reference linac target signal and the 
trajectory log data was investigated further by comparing the beam-on time recorded by 
both data sources for all segments as well as the time between the activation of consecutive 
segments. Further information on this analysis can be found in appendix B of the supple-
mentary mat erials. From the analysis it was observed that the beam-on flags recorded in 
the trajectory log files consistently overestimated the beam-on period for each segment by 
28.58  ±  11.74 ms. However, the trajectory log files also underestimated the time between 
the activation of consecutive segments by  −9.99  ±  8.33 ms. This underestimation of 
the time between the activation of consecutive segments was the result of the beam-off 
period between consecutive segments being underestimated in the trajectory log files by 
38.57  ±  14.40 ms.
3.4. Gamma analysis
An example of the method used to perform gamma analysis on moving acquisitions is shown 
in figure 5 for a 4 s breathing period, where no gating was applied to the exposure. Figure 5(a) 
displays the dose distribution acquired during a static acquisition, this has been convolved 
with the PDF for a 2.5 cm sinusoidal oscillation that has no amplitude constraints applied 
(figure 5(b)) to generate the expected 2D dose distribution (figure 5(c)). The resulting gamma 
distribution from the comparison of the expected dose fluence with the dose fluence that was 
actually measured (figure 5(d)) is displayed in figure 5(e). Gamma pass criteria of 1% dose 
difference and 1 mm distance-to-agreement have been used to perform this analysis, with a 
low dose threshold of 10% and the % dose difference defined relative to the maximum dose. 
In this example a 100% pass rate was achieved for all pixels.
The same analysis was repeated on all of the gated exposures for each of the four 
TrueBeams. The results of this analysis are summarised in table 3 for TrueBeam versions 1.5 
and 2.0. Gamma analysis using pass criteria of 2%/2 mm was found to yield 100% pass-rates 
for all exposures, therefore finer gamma criteria of 1%/1 mm and 0.5%/0.5 mm were investi-
gated to identify the limiting criteria. Using gamma criteria of 1%/1 mm only one gated expo-
sure was found to have a pass rate less than 100%. Further analysis of this exposure indicated 
that the peak dose in the measured fluence was 1.636 Gy, 0.6% higher than the average peak 
dose (1.626  ±  0.003 Gy). 50% of the measured fluences were observed to achieve pass-rates 
above 90% when finer criteria of 0.5%/0.5 mm were used.
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4. Discussion
4.1. Geometric and dosimetric accuracy
This study used a novel acquisition arrangement, where the OCTAVIUS SRS 1000 2D array 
was combined with a moving platform, to enable time-resolved dose fluence measurements 
from a moving frame of reference. This arrangement allowed assessment of the geometric 
and dosimetric accuracy of the Varian RPM system installed on four TrueBeam linacs under 
a range of gating conditions and breathing periods. The asymmetry observed in the temporal 
trace derived from the SRS array analysis displayed in figure 3 indicated a short delay between 
the RPM gating constraints being met and the linac exposure being activated/deactivated. This 
asymmetry was observed in the analysis of all the gated exposures and the presence of a time 
delay agrees with another study (McCabe and Wiersma 2014) that reported an average of 
14 ms (3–30 ms) delay between the RPM beam-enable gate and the activation of the MV expo-
sure. Analysis of the time-resolved spatial data acquired with this new phantom arrangement 
Figure 5. Gamma analysis of integrated dose fluences. (a) 2D dose fluence acquired 
with SRS array stationary. (b) Expected PDF for 2.5 cm sinusoidal oscillation. 
(c) Calculated dose distribution resulting from convolution of PDF with static dose 
fluence. (d) Measured dose fluence when platform oscillated with period of 4 s and no 
gating was applied to exposure. (e) Results of gamma analysis comparing the two 2D 
dose fluences.
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suggested that the effect of this delay was negligible, as only small differences (<0.42 mm) 
were observed between the expected and measured average position of the phantom for each 
of the gating settings.
The breathing periods used throughout this investigation correspond to realistic breath-
ing periods interpreted from the results reported by Seppenwoolde et al (2002). For gating 
setting B, these periods are equivalent to average velocities in the range of 1.3–2.5 mm s−1. 
Woods and Rong (2015) observed a trend in this velocity range, where the delay between gat-
ing constraints being met and the activation of the MV exposure varied as a function of the 
phantom velocity. In their study, the authors observed an increasing delay as the velocity was 
increased, up to speeds of 5 mm s−1. However, analysis of the results reported here suggests 
that this velocity-dependent delay did not result in any noticeable differences in the mean 
position of the phantom position for the three breathing periods investigated.
The accuracy of the RPM system was further validated through the results of the gamma 
analysis comparing measured and expected dose fluences. All the exposures analysed had 
100% pass rates using 2%/2 mm criteria and only one exposure had a pass rate less than a 
100% when gamma criteria of 1%/1 mm was used. To provide a like-for-like comparison, this 
study took into account the blurring of the dose fluence that occurs as a result of the phantom 
motion during gated segments. However, similar results with gamma criteria of 1%/1 mm 
were observed by Duan et al (2003) when they compared IMRT dose fluences acquired using 
film during either static or gated acquisitions where a 25% duty cycle was applied.
Analysis of fluences acquired from versions v1.5 and v2.0 of TrueBeam indicated that 
the limiting gamma criteria, where differences between the expected and measured fluences 
could be clearly distinguished, were of the order of 0.5%/0.5 mm. This 0.5 mm distance-to-
agreement criterion is of a similar magnitude to the absolute differences reported in table 1, 
although it is noted that these gamma criteria are within the expected measurement uncer-
tainty for this experimental arrangement. To test this analysis, gamma comparisons of fluences 
acquired under the same gating constraints but with different breathing periods were also 
performed using pass criteria of 0.5%/0.5 mm. Excellent agreement was found for exposures 
performed on the same linac under the same setup conditions (average pass rate  =  94.1%). 
The technique was found to be sensitive to different setup conditions between the four linacs 
Table 3. Results of gamma analysis comparing expected and measured 2D dose 
fluences for two TrueBeam models.
Breathing  
Period (s)
Gating  
Setting
TrueBeam v1.5 (I) TrueBeam v2.0
1%/1 mm 0.5%/0.5 mm 1%/1 mm 0.5%/0.5 mm
3 A 100 86.4 100.0 88.9
B 100 100.0 100.0 100.0
C 100 94.0 100.0 100.0
D 100 85.6 100.0 90.4
4 A 100 92.8 100.0 93.7
B 100 100.0 100.0 95.5
C 100 87.1 100.0 93.3
D 100 60.5 100.0 95.1
6 A 100 85.0 100.0 85.3
B 91.9 48.2 100.0 77.8
C 100 89.6 100.0 81.4
D 100 69.3 100.0 92.0
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and exposures performed on different days, measured pass rates for this analysis were typi-
cally less than 75%. The position uncertainties are similar in magnitude to a clinical study by 
Ford et al (2002) who analysed cine mode portal images to determine the intrafraction motion 
for two patients receiving gated treatment exposures. From analysis of the cine images, the 
authors determined that the intrafraction motion during the gated exposures was less than 
1.4 mm for both patients. Our results provide further evidence that the RPM system can accu-
rately track the position of the marker block and successfully perform gated x-ray exposures 
with sub mm resolution.
4.2. Inconsistent data logging
Although the SRS array data indicated that the gating system consistently operated as 
expected, subsequent analysis found that the RPM software installed on TrueBeam versions 
1.5 and 1.6 did not reliably record the correct position trace or beam-enable/disable gates. This 
intermittent discrepancy in the RPM data was not observed in any of the TrueBeam v2.0 expo-
sures. While the operation of the RPM system was not expected to change between TrueBeam 
iterations, previous work by our group has highlighted the need to test new versions of clinical 
software as unexpected changes in their operation can occur (McGarry et al 2011). Further 
evidence that indicated the presence of TrueBeam version-specific changes to the RPM sys-
tem was the improved consistency in the delay derived to synchronise TrueBeam v2.0 log file 
data with the RPM-generated data. While Woods and Rong (2015) also evaluated multiple 
TrueBeam linacs, their report did not include details of the TrueBeam versions investigated 
and no version-specific trends were described. Therefore, to the best of our knowledge, this 
is the first study to compare the operation of the RPM system between different iterations of 
TrueBeam linac using information recorded by multiple data sources.
Analysis of results acquired using this phantom arrangement also highlighted a trend in the 
beam-on flags recorded in the trajectory log files, which consistently occurred prior to the true 
target signal. A number of studies have used data contained within linac log files to perform 
pre-treatment verification of the successful delivery of planned treatments (e.g. Litzenberg et al 
2002, Agnew et al 2012, Sun et al 2013) and the timing accuracy of the log data is of particular 
relevance for verifying gated treatments. Qian et al (2011) extended this work to the verifica-
tion of gated-VMAT treatments where they observed 100% pass rates when comparing dose 
distributions reconstructed from log files of gated irradiations to planned distributions using 
conventional gamma criteria of 3%/3 mm. Unlike the current study, Qian et al did not correlate 
the activation of the linac exposure with the position of the respiration phantom. If log files are 
to be used to verify the delivery of gated treatments then accurate interpretation of the data stored 
within these log files is paramount. For this analysis to be meaningful a complete understanding 
of potential trajectory log discrepancies, such as those observed within this study, is essential.
5. Conclusion
This study reports on the development of a moving detector arrangement that enables time-
resolved dosimetry for the purpose of verifying the delivery of gated radiotherapy treatments. In 
this investigation the arrangement was used to evaluate the accuracy of the RPM system during 
a series of gated irradiation scenarios. The phantom arrangement exposed a number of erroneous 
trends in the data recorded by the RPM system and in the linac trajectory log files. However, as 
the 2D array 1%/1 mm gamma pass rates showed, the timing discrepancies in the various linac 
output files had little to no impact on the accurate delivery of the gated treatment fields.
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